Page last updated: 2024-10-30

mecamylamine and Systemic Inflammatory Response Syndrome

mecamylamine has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Z1
Bai, X1
Du, K1
Huang, Y1
Wang, W1
Zhao, Y1
Pei, Y1
Mu, J1
Han, H1
Hu, S1
Li, S1
Dong, H1
Lu, Y1
Hou, L1
Xiong, L1

Other Studies

1 other study available for mecamylamine and Systemic Inflammatory Response Syndrome

ArticleYear
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
    The Journal of surgical research, 2012, May-15, Volume: 174, Issue:2

    Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Mal

2012